Literature DB >> 11129530

Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH).

J Antinheimo1, S L Sallinen, P Sallinen, H Haapasalo, H Helin, N Horelli-Kuitunen, M Wessman, M Sainio, J Jääskeläinen, O Carpén.   

Abstract

BACKGROUND: Schwannomas occur sporadically or in association with neurofibromatosis 2 (NF2), an autosomal dominant disorder, which predisposes to multiple schwannomas, meningiomas and spinal ependymomas, with bilateral vestibular schwannomas as the classic hallmark. As NF2 and sporadic schwannomas differ in some respect in their clinical and biological behavior we evaluated whether there are any differences in the distribution of genetic aberrations between NF2 and sporadic schwannomas. Our interest was also to verify whether secondary genetic alterations besides the loss of 22q could be detected in schwannomas.
METHODS: We investigated DNA copy number changes in 25 schwannomas (12 NF2 and 13 sporadic schwannomas) using the comparative genomic hybridization (CGH) technique. Some chromosomal regions were further studied by LOH or FISH analysis.
FINDINGS: CGH detected genomic abnormalities in 15 of 25 schwannomas (60%). The most common alteration was loss on 22q, found in 32% (8/25) of schwannomas. No consistent changes were detected in other chromosomal regions. The overall number of genetic aberrations was similar in NF2 and in sporadic schwannomas.
INTERPRETATION: Our results support the present view that loss of chromosome 22q harboring the NF2 gene plays a universal role in the pathogenesis of schwannomas without consistent involvement of other chromosomal regions.

Entities:  

Mesh:

Year:  2000        PMID: 11129530     DOI: 10.1007/s007010070036

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  19 in total

1.  Analysis of cytogenetic aberrations in sporadic vestibular schwannoma by comparative genomic hybridization.

Authors:  Dimitrios Koutsimpelas; Uwe Felmeden; Wolf J Mann; Jürgen Brieger
Journal:  J Neurooncol       Date:  2010-09-26       Impact factor: 4.130

2.  Expression analysis of tumor-related genes involved in critical regulatory pathways in schwannomas.

Authors:  Miguel Torres-Martín; Victor Martinez-Glez; Carolina Peña-Granero; Luis Lassaletta; Alberto Isla; Jose M de Campos; Giovanny R Pinto; Rommel R Burbano; Bárbara Meléndez; Javier S Castresana; Juan A Rey
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

3.  Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.

Authors:  Ramita Dewan; Alex Pemov; H Jeffrey Kim; Keaton L Morgan; Raul A Vasquez; Prashant Chittiboina; Xiang Wang; Settara C Chandrasekharappa; Abhik Ray-Chaudhury; John A Butman; Douglas R Stewart; Ashok R Asthagiri
Journal:  Neuro Oncol       Date:  2014-12-01       Impact factor: 12.300

4.  Comparative genomic hybridization and mutation analyses of sporadic schwannomas.

Authors:  Takayuki Ikeda; Sho Hashimoto; Shinichi Fukushige; Hiroaki Ohmori; Akira Horii
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

5.  NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH.

Authors:  Irene Szijan; Daniel Rochefort; Carl Bruder; Ezequiel Surace; Gloria Machiavelli; Viviana Dalamon; Javier Cotignola; Veronica Ferreiro; Alvaro Campero; Armando Basso; Jan P Dumanski; Guy A Rouleau
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 6.  Peripheral nerve tumors: management strategies and molecular insights.

Authors:  Asis Kumar Bhattacharyya; Richard Perrin; Abhijit Guha
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

7.  High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.

Authors:  Teresita Díaz de Ståhl; Caisa M Hansson; Cecilia de Bustos; Kiran K Mantripragada; Arkadiusz Piotrowski; Magdalena Benetkiewicz; Caroline Jarbo; Leif Wiklund; Tiit Mathiesen; Gunnar Nyberg; V Peter Collins; D Gareth Evans; Koichi Ichimura; Jan P Dumanski
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

Review 8.  Merlin, the NF2 gene product.

Authors:  Nives Pećina-Šlaus
Journal:  Pathol Oncol Res       Date:  2013-05-12       Impact factor: 3.201

9.  Surgical strategies for managing foraminal nerve sheath tumors: the emerging role of CyberKnife ablation.

Authors:  Judith A Murovic; S Charles Cho; Jon Park
Journal:  Eur Spine J       Date:  2009-10-02       Impact factor: 3.134

10.  DNA copy gains of tumor-related genes in vestibular schwannoma.

Authors:  Luis Lassaletta; Miguel Torres-Martín; Jesús San-Román-Montero; Javier S Castresana; Javier Gavilán; Juan Antonio Rey
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-21       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.